Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.
Visceral leishmaniasis is common in less developed countries, with an estimated 500000 new cases each year. Because of the diversity of epidemiological situations, no single diagnosis, treatment, or control will be suitable for all. Control measures through case finding, treatment, and vector contro...
Main Authors: | Guerin, P, Olliaro, P, Sundar, S, Boelaert, M, Croft, S, Desjeux, P, Wasunna, M, Bryceson, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Evaluating drug resistance in visceral leishmaniasis: the challenges
by: Hendrickx, S, et al.
Published: (2016) -
Liposomal amphotericin B in drug-resistant visceral leishmaniasis.
by: Davidson, R, et al.
Published: (1991) -
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.
by: Olliaro, P, et al.
Published: (2005) -
Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.
by: Vanlerberghe, V, et al.
Published: (2007) -
Relationship of serum antileishmanial antibody with development of visceral leishmaniasis, post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse
by: Mondal, D, et al.
Published: (2019)